Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Dianthus Therapeutics, Inc. (DNTH) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Dianthus Therapeutics, Inc. (DNTH) on November 12, 2026 is 91.33 $, +2.27 % on the day. Over 52 weeks the stock traded between 34.29 $ and 117.88 $; the price now sits 68 % of the way up that range. Over the past year the price changed by +126.08 %. Market capitalization is 4.92 billion $, rank 42 among 384 stocks of the same industry with a known capitalization.
Dianthus Therapeutics, Inc. trades on Nasdaq under the ticker DNTH. The company belongs to the Health care sector. The trading history on this page starts on 21 June 2018.
Over the past 52 weeks DNTH has traded between 34.29 $ and 117.88 $. As of 12 November 2026 the price stood 63.70% of the way from the 52-week low to the high.
Over one year DNTH shares rose 126.08%; over six months they rose 2.58%. Volatility over 90 days is 46.49%. Dividends are not included: this is price change only, as of 12 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 2,416, above the sector median of 3.9. Price to book is 4.2, above the sector median of 2.4. Calculated from reports for the period ending 30 June 2026.
DNTH has a return on equity of −16.40%, above the sector median of −40.58%. Return on assets is −15.85%, above the sector median of −30.08%.